Ordered to be Reported by Voice Vote.
The bill amends the Research and Development, Competition, and Innovation Act to fund and coordinate measurement research and consensus standards for nucleic acid synthesis screening. It directs NIST to research testing, best practices, technical guidance, conformity assessment, and evaluation methods, convene a stakeholder consortium, require a report within 18 months, and authorizes $5 million annually for FY2026–2030 for these activities.
Progressives emphasize civil-liberties safeguards and public-interest oversight
Relative to its intended legislative type, this bill is a focused administrative/operational statute that clearly inserts a new NIST activity into an existing statutory framework, prescribes research and convening tasks, and authorizes multi-year funding.
The bill amends the Research and Development, Competition, and Innovation Act to fund and coordinate measurement research and consensus standards for nucleic acid synthesis screening.
It directs NIST to research testing, best practices, technical guidance, conformity assessment, and evaluation methods, convene a stakeholder consortium, require a report within 18 months, and authorizes $5 million annually for FY2026–2030 for these activities.
Small, technical, bipartisan‑friendly authorization with stakeholder input; main barriers are procedural, not substantive.
Relative to its intended legislative type, this bill is a focused administrative/operational statute that clearly inserts a new NIST activity into an existing statutory framework, prescribes research and convening tasks, and authorizes multi-year funding. It adequately identifies responsible entities, topical priorities, and an initial reporting requirement, but leaves several implementation details and safeguards to be resolved in practice.
Progressives emphasize civil-liberties safeguards and public-interest oversight
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize civil-liberties safeguards and public-interest oversight
Likely broadly supportive as a targeted, science-based biosecurity measure that funds standards development and stakeholder input.
Would want explicit safeguards for transparency, civil liberties, and equitable public-interest representation.
Some impacts, like effects on research access, are uncertain without implementation details.
Generally favorable as a narrowly focused, modestly funded federal role to improve technical standards and reduce biosecurity risks.
Would emphasize clear metrics, interagency coordination, and minimizing regulatory friction for small businesses and research labs.
Cautiously skeptical; supports biosecurity goals but worries about federal expansion, regulatory burden, and privacy or IP exposure.
Would prefer voluntary, industry-led standards and tight limits on federal authority and spending increases.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Small, technical, bipartisan‑friendly authorization with stakeholder input; main barriers are procedural, not substantive.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize civil-liberties safeguards and public-interest oversight
Small, technical, bipartisan‑friendly authorization with stakeholder input; main barriers are procedural, not substantive.
Relative to its intended legislative type, this bill is a focused administrative/operational statute that clearly inserts a new NIST activity into an existing statutory framework, prescribes research and convening tasks…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.